BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2166 related articles for article (PubMed ID: 17113430)

  • 1. Retinitis pigmentosa.
    Hartong DT; Berson EL; Dryja TP
    Lancet; 2006 Nov; 368(9549):1795-809. PubMed ID: 17113430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
    Arch Ophthalmol; 2004 Sep; 122(9):1306-14. PubMed ID: 15364709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
    Arch Ophthalmol; 2004 Sep; 122(9):1297-305. PubMed ID: 15364708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
    Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFranco C; Willett W
    Arch Ophthalmol; 1993 Jun; 111(6):761-72. PubMed ID: 8512476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Willett WC
    Arch Ophthalmol; 2012 Jun; 130(6):707-11. PubMed ID: 22332205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Pharmacological Concepts in the Treatment of the Retinitis Pigmentosa.
    Huang XF
    Adv Exp Med Biol; 2018; 1074():439-445. PubMed ID: 29721974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular phenotype of bothnia dystrophy, an autosomal recessive retinitis pigmentosa associated with an R234W mutation in the RLBP1 gene.
    Burstedt MS; Forsman-Semb K; Golovleva I; Janunger T; Wachtmeister L; Sandgren O
    Arch Ophthalmol; 2001 Feb; 119(2):260-7. PubMed ID: 11176989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early therapeutic trials for retinitis pigmentosa].
    Dufier JL
    Bull Acad Natl Med; 2003; 187(9):1685-92; discussion 1692-4. PubMed ID: 15369238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial.
    Rotenstreich Y; Belkin M; Sadetzki S; Chetrit A; Ferman-Attar G; Sher I; Harari A; Shaish A; Harats D
    JAMA Ophthalmol; 2013 Aug; 131(8):985-92. PubMed ID: 23700011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa.
    Berson EL; Weigel-DiFranco C; Rosner B; Gaudio AR; Sandberg MA
    JAMA Ophthalmol; 2018 May; 136(5):490-495. PubMed ID: 29596553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vision threshold profiles in X-linked retinitis pigmentosa.
    Massof RW; Finkelstein D
    Invest Ophthalmol Vis Sci; 1979 Apr; 18(4):426-9. PubMed ID: 311766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acuity recovery and cone pigment regeneration after a bleach in patients with retinitis pigmentosa and rhodopsin mutations.
    Sandberg MA; Pawlyk BS; Berson EL
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2457-61. PubMed ID: 10476820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of night-blindness with vitamins A and E.
    Hanna MB
    Bull Ophthalmol Soc Egypt; 1965; 58(62):219-24. PubMed ID: 5297924
    [No Abstract]   [Full Text] [Related]  

  • 17. Retinitis pigmentosa inversa.
    Ferrucci S; Anderson SF; Townsend JC
    Optom Vis Sci; 1998 Aug; 75(8):560-70. PubMed ID: 9734800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype of retinitis pigmentosa associated with the Ser50Thr mutation in the NRL gene.
    Bessant DA; Holder GE; Fitzke FW; Payne AM; Bhattacharya SS; Bird AC
    Arch Ophthalmol; 2003 Jun; 121(6):793-802. PubMed ID: 12796249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress of treatment strategies for retinitis pigmentosa].
    Qian TW; Xu X
    Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):148-153. PubMed ID: 28260368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhodopsin and visual threshold in retinitis pigmentosa.
    Ripps H; Brin KP; Weale RA
    Invest Ophthalmol Vis Sci; 1978 Aug; 17(8):735-45. PubMed ID: 681133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 109.